Kristina Callis Duffin has not added Biography.
If you are Kristina Callis Duffin and would like to personalize this page please email our Author Liaison for assistance.
Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking.
The Journal of investigative dermatology Dec, 2009 | Pubmed ID: 19554022
Multiple Loci within the major histocompatibility complex confer risk of psoriasis.
PLoS genetics Aug, 2009 | Pubmed ID: 19680446
Obesity in early adulthood as a risk factor for psoriatic arthritis.
Archives of dermatology Jul, 2010 | Pubmed ID: 20644032
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients.
Journal of the American Academy of Dermatology Mar, 2012 | Pubmed ID: 21856040
Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis.
Journal of drugs in dermatology : JDD Feb, 2012 | Pubmed ID: 22270196
Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting.
Archives of dermatology Apr, 2012 | Pubmed ID: 22508874
Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis.
Archives of dermatology Apr, 2012 | Pubmed ID: 22508884
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
American journal of human genetics May, 2012 | Pubmed ID: 22521419
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.
Journal of the American Academy of Dermatology Jan, 2013 | Pubmed ID: 22846688
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.
Journal of the American Academy of Dermatology Feb, 2013 | Pubmed ID: 22910105
Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials--reply.
JAMA dermatology Apr, 2013 | Pubmed ID: 23715064
Practice GAPS: preventing and detecting antibodies to anti-tumor necrosis factor agents: gaps in practice or in evidence?
JAMA dermatology Feb, 2014 | Pubmed ID: 24352167
Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis.
Journal of the American Academy of Dermatology Oct, 2014 | Pubmed ID: 24894455
Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.
Journal of the American Academy of Dermatology Oct, 2014 | Pubmed ID: 24928705
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
Journal of the American Academy of Dermatology Dec, 2014 | Pubmed ID: 25260564
A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.
The New England journal of medicine Jul, 2015 | Pubmed ID: 26154787
Desired Improvement Tool (DIT): A tool to assess desire for improvement in psoriasis patients.
The Journal of dermatological treatment , 2016 | Pubmed ID: 26247843
Validity of the Simple-Measure for Assessing Psoriasis Activity (S-MAPA) for objectively evaluating disease severity in patients with plaque psoriasis.
Journal of the American Academy of Dermatology Nov, 2015 | Pubmed ID: 26475541
Usability of a novel disposable autoinjector device for ixekizumab: results from a qualitative study and an open-label clinical trial, including patient-reported experience.
Medical devices (Auckland, N.Z.) , 2016 | Pubmed ID: 27785115
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis.
Journal of the American Academy of Dermatology Feb, 2017 | Pubmed ID: 27908543
Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series.
JAAD case reports Sep, 2017 | Pubmed ID: 28932788
The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA.
Psoriasis (Auckland, N.Z.) , 2018 | Pubmed ID: 30324088
A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies.
BMC dermatology Jun, 2019 | Pubmed ID: 31174539
Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis Registry.
Dermatology (Basel, Switzerland) , 2021 | Pubmed ID: 31962340
Promoting Diversity, Equity, and Inclusion for Psoriatic Diseases.
The Journal of rheumatology Jun, 2022 | Pubmed ID: 35293335
Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
The Journal of rheumatology Jan, 2023 | Pubmed ID: 36319014
Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis.
The Journal of rheumatology Nov, 2023 | Pubmed ID: 37657796
PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries.
Arthritis care & research Mar, 2024 | Pubmed ID: 37691268
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved